Vamagloxistat

N/A

Report date: 2025/05/20 15:34:39

NME

Base Information

Drug NameVamagloxistat

Drug Alias NameBBP-711ORF-229

ClassificationSmall molecules

Mechanisms of ActionOxalates inhibitors

TargetsOxalates

Therapy Area/IndicationsHyperoxaluria, Primary

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesBridgebio Pharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesOrfan Biotech Inc Cantero Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsHyperoxaluria, Primary

Inactive IndicationsN/A

Other Information

ATC CodeN/A

Related LinksN/A